Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canaryseed Development Commission of Saskatchewan (CDCS) is a producer-led organization established to grow the canaryseed industry through research, market development, and advocacy. A major milestone for the commission was securing regulatory approval from Health Canada and the U.S. FDA for glabrous (hairless) canaryseed for human consumption. The organization focuses on the nutritional benefits of canaryseed, particularly its status as a high-protein, gluten-free cereal grain suitable for various food applications. CDCS collaborates with researchers to explore the grain's potential in addressing dietary needs for celiac patients and enhancing the nutritional profile of plant-based foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canaryseed Development Commission of Saskatchewan.